Gross profit rose three per cent, up from £101.7m in 2022 to £105m this year, with the company singling out particularly strong sales in its Kelo-Cote franchise. Alliance Pharma confirmed that ...
Alliance Pharma plc (AIM ... strong revenue growth for the Kelo-Cote franchise drove Group see-through* revenues of £84.8m in the Period (H1 23: £82.4m), up 2.8% versus the prior period and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback